BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20072157)

  • 1. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
    Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.
    Sharma A; Jyotsana N; Gabdoulline R; Heckl D; Kuchenbauer F; Slany RK; Ganser A; Heuser M
    Haematologica; 2020 May; 105(5):1294-1305. PubMed ID: 31413090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
    Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T
    Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
    Carella C; Bonten J; Rehg J; Grosveld GC
    Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
    Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
    Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
    Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
    Zeisig BB; García-Cuéllar MP; Winkler TH; Slany RK
    Oncogene; 2003 Mar; 22(11):1629-37. PubMed ID: 12642866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo.
    Takacova S; Slany R; Bartkova J; Stranecky V; Dolezel P; Luzna P; Bartek J; Divoky V
    Cancer Cell; 2012 Apr; 21(4):517-31. PubMed ID: 22516260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia.
    Eguchi M; Eguchi-Ishimae M; Knight D; Kearney L; Slany R; Greaves M
    Genes Chromosomes Cancer; 2006 Aug; 45(8):754-60. PubMed ID: 16688745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia.
    Heuser M; Park G; Moon Y; Berg T; Xiang P; Kuchenbauer F; Vollett S; Lai C; Humphries RK
    Exp Hematol; 2010 Mar; 38(3):174-9. PubMed ID: 20096329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.
    Gurevich RM; Rosten PM; Schwieger M; Stocking C; Humphries RK
    Exp Hematol; 2006 Sep; 34(9):1192-201. PubMed ID: 16939812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.
    Bergerson RJ; Collier LS; Sarver AL; Been RA; Lugthart S; Diers MD; Zuber J; Rappaport AR; Nixon MJ; Silverstein KA; Fan D; Lamblin AF; Wolff L; Kersey JH; Delwel R; Lowe SW; O'Sullivan MG; Kogan SC; Adams DJ; Largaespada DA
    Blood; 2012 May; 119(19):4512-23. PubMed ID: 22427200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.